Table 2 Distribution of 68Ga-PSMA avid sites of prostate cancer involvement
From: 68Ga-PSMA PET/CT in prostate cancer patients – patterns of disease, benign findings and pitfalls
No studies (%) | SUVmax (range) | |
|---|---|---|
N = 319 | 72% | |
Prostate | 193 (43%) | 11.3 (2–61) |
Loco-regional spread | 51 (11%) | 13 (2–78) |
Abdomino-pelvic nodal metastases | 129 (29%) | 12 (1.4–100) |
Distant metastases | 158 (36%) | |
Bone metastases | 111 (25%) | 12.5 (1.9–91) |
Distant nodes | 29 (7%) | 11.3 (1.5–58) |
Othera | 18 (4%) | 7.1 (1.8–14.6) |